Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ronald Renaud Insider Profile
4 Followers
Ronald Renaud, Director at Akebia Therapeutics, holds 244.31K shares in Cerevel Therapeutics Holdings (Ticker: CERE), holds 31.50K shares in Atara Biotherapeutics (Ticker: ATRA), holds 0.00 shares in Translate Bio (Ticker: ~TBIO).
Profitable Transactions
4 out of 5 Profitable Transactions
Average Return
+78.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Ronald Renaud holds in companies
Most Profitable Insider Trade
Stock:
Translate Bio
(~TBIO)
(~TBIO)
Rating:Informative Buy
Date:Apr 09, 2021 - Apr 09, 2022
Return:+120.00%
The most profitable trade made by Ronald Renaud
Ronald Renaud's Trading History
Akebia Therapeutics
Dec 02, 2014
Director
Informative Buy
59.55K
$6.15K
Translate Bio
Sep 14, 2021
―
Informative Sell
36.25M
$0.00
Atara Biotherapeutics
Jun 27, 2022
Director
Uninformative Buy
―
$19.06K
Ikena Oncology
―
Director
―
―
Cerevel Therapeutics Holdings
Dec 21, 2023
President & CEO, Director
Uninformative Buy
―
$10.32M
Chimerix
―
Director
―
$0.00
PTC Therapeutics
―
Director
―
$0.00
Keryx Biopharma
―
―
―
$315.93K
Idenix Pharma
―
―
―
―
List of latest transactions for each holding click on a transaction to see Ronald Renaud's performance on stock
You May Also Like
Ronald Renaud insider profile FAQ
What is the percentage of profitable transactions made by Ronald Renaud?
The percentage of profitable transactions made by Ronald Renaud is 80%.
What is the average return per transaction made by Ronald Renaud?
The average return per transaction made by Ronald Renaud is 78.10%.
What stocks does Ronald Renaud hold?
Ronald Renaud holds: AKBA, ~TBIO, ATRA, IKNA, CERE, CMRX, PTCT, KERX, IDIX stocks.
What was Ronald Renaud’s latest transaction?
Ronald Renaud latest transaction was an Uninformative Buy of ―.
What was Ronald Renaud's most profitable transaction?
Ronald Renaud’s most profitable transaction was an Informative Buy of ~TBIO stock on April 9, 2021. The return on the trade was 120.00%.
What is Ronald Renaud's role in Akebia Therapeutics?
Ronald Renaud's role in Akebia Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.